SEC-sourced researchBeta
AVHHL
AVITA Medical, Inc.
Company comparison ↗
Data passport
- CIK
- 0001762303
- Exchange
- OTC
- Business activity
- Surgical & Medical Instruments & Apparatus · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Nov 13, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 64,251,000.0000 | Feb 12, 2026 |
| December 2025 | 71,610,000.0000 | Feb 12, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 71,610,000.0000 | -48,587,000.0000 | -31,195,000.0000 | 56,392,000.0000 | 73,042,000.0000 | Feb 12, 2026 |
| December 2024 | 64,251,000.0000 | -61,845,000.0000 | -48,939,000.0000 | 79,711,000.0000 | 74,968,000.0000 | Feb 12, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
32/100
Profitability0
Growth61
Balance sheet0
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $71.61M | Jan 1, 2025 – Dec 31, 2025 | Feb 12, 2026 | 10-K |
| Previous period revenueRevenues | $64.25M | Jan 1, 2024 – Dec 31, 2024 | Feb 12, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$48.59M | Jan 1, 2025 – Dec 31, 2025 | Feb 12, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$31.2M | Jan 1, 2025 – Dec 31, 2025 | Feb 12, 2026 | 10-K |
| Total assetsAssets | $56.39M | Dec 31, 2025 | Feb 12, 2026 | 10-K |
| Total liabilitiesLiabilities | $73.04M | Dec 31, 2025 | Feb 12, 2026 | 10-K |